Financials
- Market Capitalization 1.11 T
- Employee 50 K
- Founded N/A
- CEO Kenji Tanaka
- Website www.lilly.com
- Headquarter Indiana, United States
- FIGI BBG000BNBDC2
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 20 | JNJ Johnson & Johnson Common Stock | 265.76 USD | -1.59% | -0.87% | -1.00% | +51.16% | 640.45 B USD | ||
| 23 | ABBV AbbVie Inc. Common Stock | 258.02 USD | -1.82% | -1.14% | -2.36% | +24.10% | 455.95 B USD | ||
| 34 | MRK Merck & Company, Inc. Common Stock | 149.54 USD | -2.32% | +0.25% | +12.83% | +79.26% | 368.94 B USD | ||
| 46 | NVS Novartis AG | 154.65 USD | -1.84% | -0.97% | -2.86% | +22.54% | 295.10 B USD |
Frequently asked questions about Eli Lilly & Co.
What is the Eli Lilly & Co. stock price today?
The current price of Eli Lilly & Co. (LLY) is 1175.12. Over the past 24 hours, the stock has changed by -1.18%. Follow the LLY chart for real-time price dynamics.
What is the stock ticker of Eli Lilly & Co.?
Eli Lilly & Co. trades under the ticker LLY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Eli Lilly & Co. stock going up?
LLY has changed by -4.52% over the last week, -3.30% over the last month, and +60.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Eli Lilly & Co.?
Eli Lilly & Co. currently has a market capitalization of 1.11 T. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Eli Lilly & Co. release financial reports?
Yes. You can track Eli Lilly & Co. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Eli Lilly & Co. earnings last quarter?
Last quarter, Eli Lilly & Co. reported earnings of 7.95 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Eli Lilly & Co. revenue for the last quarter?
Eli Lilly & Co. reported quarterly revenue of 22.97 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Eli Lilly & Co. net income for the last quarter?
Eli Lilly & Co. reported net income of 7.09 B for the last quarter. The previous quarter showed 7.4 B, which means net income changed by -4.07%.
Does Eli Lilly & Co. pay dividends?
Eli Lilly & Co. paid a dividend per share of 3.46. The current dividend yield is 1.31%. Dividend data can help income-focused investors evaluate the stock.
How many employees does Eli Lilly & Co. have?
As of the latest available data, Eli Lilly & Co. has 50 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Eli Lilly & Co. EBITDA?
Eli Lilly & Co. EBITDA is 9.51 B, and its EBITDA margin is 41.4%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Eli Lilly & Co. stock?
You can buy Eli Lilly & Co. (LLY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Eli Lilly & Co. stock?
Investing in Eli Lilly & Co. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LLY chart and related analysis on metatrader.com as part of your research.